Clinical Schizophrenia & Related Psychoses

Google Scholar citation report

Citations : 6601

Clinical Schizophrenia & Related Psychoses received 6601 citations as per Google Scholar report

Clinical Schizophrenia & Related Psychoses peer review process verified at publons

Indexed In

Citations Report

Clinical Schizophrenia & Related Psychoses : Citations & Metrics Report

Articles published in Clinical Schizophrenia & Related Psychoses have been cited by esteemed scholars and scientists all around the world. Clinical Schizophrenia & Related Psychoses has got h-index 41, which means every article in Clinical Schizophrenia & Related Psychoses has got 41 average citations.

Following are the list of articles that have cited the articles published in Clinical Schizophrenia & Related Psychoses.

	2022	2021	2020	2019	2018
Total published articles	105	141	28	8	28
Conference proceedings	0	0	0	0	0
Citations received as per Google Scholar, other indexing platforms and portals	543	553	590	563	587

Journal total citations count	6601
Journal impact factor	6.49
Journal 5 years impact factor	12.17
Journal cite score	11.19
Journal h-index	41
Journal h-index since 2019	26

Grover, Sandeep, Nandita Hazari, Subho Chakrabarti, and Ajit Avasthi. "Metabolic disturbances, side effect profile and effectiveness of clozapine in adolescents." Indian journal of psychological medicine 38, no. 3 (2016): 224-233. View at Publisher View at Google Scholar View at Indexing
Warren, Kimberly R., M. Patricia Ball, Stephanie Feldman, Fang Liu, Robert P. McMahon, and Deanna L. Kelly. "Exercise program adherence using a 5-kilometer (5K) event as an achievable goal in people with schizophrenia." Biological research for nursing 13, no. 4 (2011): 383-390. View at Publisher View at Google Scholar View at Indexing
Nebhinani, Naresh, Sandeep Grover, Subho Chakrabarti, Natasha Kate, and Ajit Avasthi. "A longitudinal study of change in prevalence of metabolic syndrome and metabolic disturbances 3 months after Clozapine therapy." J Ment Health Human Behav 18, no. 1 (2013): 9-17. View at Publisher View at Google Scholar View at Indexing
Delaney, Kathleen R., Karen M. Robinson, and Linda Chafetz. "Development of integrated mental health care: Critical workforce competencies." Nursing outlook 61, no. 6 (2013): 384-391. View at Publisher View at Google Scholar View at Indexing
Methapatara, Waritnan, and Manit Srisurapanont. "Pedometer walking plus motivational interviewing program for Thai schizophrenic patients with obesity or overweight: A 12?week, randomized, controlled trial." Psychiatry and clinical neurosciences 65, no. 4 (2011): 374-380. View at Publisher View at Google Scholar View at Indexing
Hyde, Natalie, Seetal Dodd, Kamalesh Venugopal, Christa Purdie, Michael Berk, and Adrienne O’Neil. "Prevalence of cardiovascular and metabolic events in patients prescribed clozapine: a retrospective observational, clinical cohort study." Current drug safety 10, no. 2 (2015): 125-131. View at Publisher View at Google Scholar View at Indexing
Grover, Sandeep, Srinivas Balachander, Subho Chakarabarti, and Ajit Avasthi. "Prescription practices and attitude of psychiatrists towards clozapine: a survey of psychiatrists from India." Asian journal of psychiatry 18 (2015): 57-65. View at Publisher View at Google Scholar View at Indexing
Grover, Sandeep, Naresh Nebhinani, Subho Chakrabarti, Ajit Avasthi, and Parmanand Kulhara. "Metabolic syndrome among patients receiving clozapine: A preliminary estimate." Indian journal of pharmacology 43, no. 5 (2011): 591. View at Publisher View at Google Scholar View at Indexing
Shoja Shafti, Saeed. "Augmentation of aripiprazole by flupenthixol decanoate in poorly responsive schizophrenia: a randomized clinical study." Psychiatry and Clinical Psychopharmacology 27, no. 3 (2017): 235-242. View at Publisher View at Google Scholar View at Indexing
Maayan, Nicola, Karla Soares-Weiser, Jun Xia, and Clive E. Adams. "Antipsychotic combinations for schizophrenia." The Cochrane database of systematic reviews 2 (2011). View at Publisher View at Google Scholar View at Indexing
Matar, Hosam E., Muhammad Qutayba Almerie, and Stephanie J. Sampson. "Fluphenazine (oral) versus placebo for schizophrenia." Cochrane Database of Systematic Reviews 6 (2018). View at Publisher View at Google Scholar View at Indexing
Ortiz?Orendain, Javier, Santiago Castiello?de Obeso, Luis Enrique Colunga?Lozano, Yue Hu, Nicola Maayan, and Clive E. Adams. "Antipsychotic combinations for schizophrenia." Cochrane Database of Systematic Reviews 6 (2017). View at Publisher View at Google Scholar View at Indexing
David, Anthony, Clive E. Adams, Maurice Eisenbruch, Seema N. Quraishi, and John Rathbone. "Depot fluphenazine decanoate and enanthate for schizophrenia." Cochrane database of systematic reviews 2 (2004). View at Publisher View at Google Scholar View at Indexing
Chakrabarti, Subho. "Clozapine resistant schizophrenia: Newer avenues of management." World Journal of Psychiatry 11, no. 8 (2021): 429. View at Publisher View at Google Scholar View at Indexing
Jones, Chris, David Hacker, Irene Cormac, Alan Meaden, and Claire B. Irving. "Cognitive behaviour therapy versus psychosocial treatments for schizophrenia." Cochrane Database of Systematic Reviews 9 (2010). View at Publisher View at Google Scholar View at Indexing
Morrison, Anthony P., Melissa Pyle, Andrew Gumley, Matthias Schwannauer, Douglas Turkington, Graeme MacLennan, John Norrie et al. "Cognitive-behavioural therapy for clozapine-resistant schizophrenia: The FOCUS RCT." Health Technology Assessment (2019). View at Publisher View at Google Scholar View at Indexing
Lee, N. Y., M. S. Roh, S. H. Kim, D. C. Jung, H. Y. Yu, K. H. Sung, I. W. Chung et al. "The prevalence of metabolic syndrome and its association with alanine aminotransferase in clozapine-treated Korean patients with schizophrenia." International clinical psychopharmacology 28, no. 2 (2013): 71-79. View at Publisher View at Google Scholar View at Indexing
Pijnenborg, Gerdina HM, Rozanne JM van Donkersgoed, Anthony S. David, and André Aleman. "Changes in insight during treatment for psychotic disorders: a meta-analysis." Schizophrenia Research 144, no. 1-3 (2013): 109-117. View at Publisher View at Google Scholar View at Indexing
Jones, Christopher, David Hacker, Alan Meaden, Irene Cormac, Claire B. Irving, Jun Xia, Sai Zhao, Chunhu Shi, and Jue Chen. "Cognitive behavioural therapy plus standard care versus standard care plus other psychosocial treatments for people with schizophrenia." Cochrane Database of Systematic Reviews 11 (2018). View at Publisher View at Google Scholar View at Indexing
DANEAU, Stéphanie, Johanne GOUDREAU, and Catherine SARRAZIN. "METHODOLOGIE." (2020). View at Publisher View at Google Scholar View at Indexing
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 ... 84 85 Next »

Google Scholar citation report

Citations : 6601

Clinical Schizophrenia & Related Psychoses peer review process verified at publons

Indexed In

PMC/PubMed Indexed Articles

Citations Report

Clinical Schizophrenia & Related Psychoses : Citations & Metrics Report

Grover, Sandeep, Nandita Hazari, Subho Chakrabarti, and Ajit Avasthi. "Metabolic disturbances, side effect profile and effectiveness of clozapine in adolescents." Indian journal of psychological medicine 38, no. 3 (2016): 224-233.

Warren, Kimberly R., M. Patricia Ball, Stephanie Feldman, Fang Liu, Robert P. McMahon, and Deanna L. Kelly. "Exercise program adherence using a 5-kilometer (5K) event as an achievable goal in people with schizophrenia." Biological research for nursing 13, no. 4 (2011): 383-390.

Nebhinani, Naresh, Sandeep Grover, Subho Chakrabarti, Natasha Kate, and Ajit Avasthi. "A longitudinal study of change in prevalence of metabolic syndrome and metabolic disturbances 3 months after Clozapine therapy." J Ment Health Human Behav 18, no. 1 (2013): 9-17.

Delaney, Kathleen R., Karen M. Robinson, and Linda Chafetz. "Development of integrated mental health care: Critical workforce competencies." Nursing outlook 61, no. 6 (2013): 384-391.

Methapatara, Waritnan, and Manit Srisurapanont. "Pedometer walking plus motivational interviewing program for Thai schizophrenic patients with obesity or overweight: A 12?week, randomized, controlled trial." Psychiatry and clinical neurosciences 65, no. 4 (2011): 374-380.

Hyde, Natalie, Seetal Dodd, Kamalesh Venugopal, Christa Purdie, Michael Berk, and Adrienne O’Neil. "Prevalence of cardiovascular and metabolic events in patients prescribed clozapine: a retrospective observational, clinical cohort study." Current drug safety 10, no. 2 (2015): 125-131.

Grover, Sandeep, Srinivas Balachander, Subho Chakarabarti, and Ajit Avasthi. "Prescription practices and attitude of psychiatrists towards clozapine: a survey of psychiatrists from India." Asian journal of psychiatry 18 (2015): 57-65.

Grover, Sandeep, Naresh Nebhinani, Subho Chakrabarti, Ajit Avasthi, and Parmanand Kulhara. "Metabolic syndrome among patients receiving clozapine: A preliminary estimate." Indian journal of pharmacology 43, no. 5 (2011): 591.

Shoja Shafti, Saeed. "Augmentation of aripiprazole by flupenthixol decanoate in poorly responsive schizophrenia: a randomized clinical study." Psychiatry and Clinical Psychopharmacology 27, no. 3 (2017): 235-242.

Maayan, Nicola, Karla Soares-Weiser, Jun Xia, and Clive E. Adams. "Antipsychotic combinations for schizophrenia." The Cochrane database of systematic reviews 2 (2011).

Matar, Hosam E., Muhammad Qutayba Almerie, and Stephanie J. Sampson. "Fluphenazine (oral) versus placebo for schizophrenia." Cochrane Database of Systematic Reviews 6 (2018).

Ortiz?Orendain, Javier, Santiago Castiello?de Obeso, Luis Enrique Colunga?Lozano, Yue Hu, Nicola Maayan, and Clive E. Adams. "Antipsychotic combinations for schizophrenia." Cochrane Database of Systematic Reviews 6 (2017).

David, Anthony, Clive E. Adams, Maurice Eisenbruch, Seema N. Quraishi, and John Rathbone. "Depot fluphenazine decanoate and enanthate for schizophrenia." Cochrane database of systematic reviews 2 (2004).

Chakrabarti, Subho. "Clozapine resistant schizophrenia: Newer avenues of management." World Journal of Psychiatry 11, no. 8 (2021): 429.

Jones, Chris, David Hacker, Irene Cormac, Alan Meaden, and Claire B. Irving. "Cognitive behaviour therapy versus psychosocial treatments for schizophrenia." Cochrane Database of Systematic Reviews 9 (2010).

Morrison, Anthony P., Melissa Pyle, Andrew Gumley, Matthias Schwannauer, Douglas Turkington, Graeme MacLennan, John Norrie et al. "Cognitive-behavioural therapy for clozapine-resistant schizophrenia: The FOCUS RCT." Health Technology Assessment (2019).

Lee, N. Y., M. S. Roh, S. H. Kim, D. C. Jung, H. Y. Yu, K. H. Sung, I. W. Chung et al. "The prevalence of metabolic syndrome and its association with alanine aminotransferase in clozapine-treated Korean patients with schizophrenia." International clinical psychopharmacology 28, no. 2 (2013): 71-79.

Pijnenborg, Gerdina HM, Rozanne JM van Donkersgoed, Anthony S. David, and André Aleman. "Changes in insight during treatment for psychotic disorders: a meta-analysis." Schizophrenia Research 144, no. 1-3 (2013): 109-117.

DANEAU, Stéphanie, Johanne GOUDREAU, and Catherine SARRAZIN. "METHODOLOGIE." (2020).